文献速递血管炎

儿童起病小血管炎中ANCA阳性及抗原特异性对肾脏疾病的预测价值

Predictive utility of ANCA positivity and antigen specificity in the assessment of kidney disease in paediatric-onset small vessel vasculitis.
PubMed 文献 · RMD Open · 2024-06-17

基于ARChiVe/儿童血管炎倡议注册数据库的回顾性临床数据,纳入406例儿童起病小血管炎患者,按ANCA阴性(41例)、MPO-ANCA阳性(129例)和PR3-ANCA阳性(236例)分组,比较诊断时及1至2年间的整体和肾脏疾病活动度与结局。结果显示MPO-ANCA阳性较PR3-ANCA阳性与诊断时更高的肾脏受累可能(OR 2.4,95%CI 1.3至4.7,p=0.008)和严重肾功能不全(KDIGO 4-5期;OR 6.04,95%CI 2.77至13.57,p<0.001)相关。

要点

  • 诊断时PR3-ANCA和MPO-ANCA阳性者整体疾病活动度高于ANCA阴性血管炎。
  • 1年内达到无活动性疾病(约68%)、改善(≥87%)或获得损伤(约58%)的可能在ANCA阳性或特异性间无显著差异。
  • 与成人ANCA相关血管炎不同,诊断后1至2年间复发可能(约11%)无显著差异。

核心结论

  • 本研究结果提示,与成人患者相比,ANCA在儿童中的预测价值存在重要的儿童特异性差异,在该人群制定治疗决策时应予考虑。

研究设计与样本

  • 回顾性分析ARChiVe/儿童血管炎倡议注册数据库的临床数据,纳入406例儿童和青少年小血管炎患者,按ANCA阴性(41例)、MPO-ANCA阳性(129例)和PR3-ANCA阳性(236例)分组,拟合广义线性模型比较诊断时及1至2年间的整体和肾脏特异性疾病活动度与结局。

主要发现

  • 诊断时PR3-ANCA和MPO-ANCA阳性者整体疾病活动度高于ANCA阴性血管炎。
  • 1年内达到无活动性疾病(约68%)、经历改善(≥87%)或获得损伤(约58%)的可能在ANCA阳性或特异性间无显著差异。
  • 与成人起病ANCA相关血管炎相反,诊断后1至2年间复发可能(约11%)在ANCA阳性或特异性间无显著差异。
  • MPO-ANCA阳性较PR3-ANCA阳性与诊断时更高的肾脏受累可能相关(OR 2.4,95%CI 1.3至4.7,p=0.008)。
  • MPO-ANCA阳性较PR3-ANCA阳性与诊断时更高的严重肾功能不全可能相关(KDIGO 4-5期;OR 6.04,95%CI 2.77至13.57,p<0.001)。

关键数值与推荐

  • MPO-ANCA阳性较PR3-ANCA阳性与诊断时肾脏受累可能更高相关(OR 2.4,95%CI 1.3至4.7,p=0.008)。
  • MPO-ANCA阳性较PR3-ANCA阳性与诊断时严重肾功能不全可能更高相关(KDIGO 4-5期;OR 6.04,95%CI 2.77至13.57,p<0.001)。
  • 诊断时肾脏病变严重程度相似的MPO-ANCA阳性者较PR3-ANCA阳性者,1年内肾功能改善(KDIGO分期改善)更可能(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of this study is to evaluate whether anti-neutrophil cytoplasmic antibody (ANCA) seropositivity and antigen specificity at diagnosis have predictive utility in paediatric-onset small vessel vasculitis. METHODS: Children and adolescents with small vessel vasculitis (n=406) stratified according to the absence (n=41) or presence of ANCA for myeloperoxidase (MPO) (n=129) and proteinase-3 (PR3) (n=236) were compared for overall and kidney-specific disease activity at diagnosis and outcomes between 1 and 2 years using retrospective clinical data from the ARChiVe/Paediatric Vasculitis Initiative registry to fit generalised linear models. RESULTS: Overall disease activity at diagnosis was higher in PR3-ANCA and MPO-ANCA-seropositive individuals compared with ANCA-negative vasculitis. By 1 year, there were no significant differences, based on ANCA positivity or specificity, in the likelihood of achieving inactive disease (~68%), experiencing improvement (≥87%) or acquiring damage (~58%). Similarly, and in contrast to adult-onset ANCA-associated vasculitis, there were no significant differences in the likelihood of having a relapse (~11%) between 1 and 2 years after diagnosis. Relative to PR3-ANCA, MPO-ANCA seropositivity was associated with a higher likelihood of kidney involvement (OR 2.4, 95% CI 1.3 to 4.7, p=0.008) and severe kidney dysfunction (Kidney Disease Improving Global Outcomes (KDIGO) stages 4-5; OR 6.04, 95% CI 2.77 to 13.57, p<0.001) at onset. Nonetheless, MPO-ANCA seropositive individuals were more likely to demonstrate improvement in kidney function (improved KDIGO category) within 1 year of diagnosis than PR3-ANCA seropositive individuals with similarly severe kidney disease at onset (p<0.001). CONCLUSIONS: The results of this study suggest important paediatric-specific differences in the predictive value of ANCA compared with adult patients that should be considered when making treatment decisions in this population.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Mann SK, Bone JN, Bosman ES, et al. Predictive utility of ANCA positivity and antigen specificity in the assessment of kidney disease in paediatric-onset small vessel vasculitis. RMD Open. 2024. PMID: 38886004. doi:10.1136/rmdopen-2024-004315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。